171 related articles for article (PubMed ID: 23064697)
1. Comparison of contamination rates between preserved and preservative-free fluoroquinolone eyedrops.
Kim MS; Kim HK; Kim JM; Choi CY
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):817-24. PubMed ID: 23064697
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
Ryan G; Fain JM; Lovelace C; Gelotte KM
BMC Ophthalmol; 2011 Apr; 11():8. PubMed ID: 21510881
[TBL] [Abstract][Full Text] [Related]
3. Are multidose over-the-counter artificial tears adequately preserved?
Charnock C
Cornea; 2006 May; 25(4):432-7. PubMed ID: 16670481
[TBL] [Abstract][Full Text] [Related]
4. Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus.
Hyon JY; Eser I; O'Brien TP
J Cataract Refract Surg; 2009 Sep; 35(9):1609-13. PubMed ID: 19683161
[TBL] [Abstract][Full Text] [Related]
5. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
6. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
Hesje CK; Borsos SD; Blondeau JM
J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of preservative effectiveness of liquid crystalline systems with retynil palmitate by the challenge test and D-value.
Chorilli M; Leonardi GR; Salgado HR; Scarpa MV
J AOAC Int; 2011; 94(1):118-27. PubMed ID: 21391488
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
Blondeau JM; Borsos S; Hesje CK
J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Rosenthal RA; Buck SL; Henry CL; Schlech BA
J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
[TBL] [Abstract][Full Text] [Related]
11. Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.
Hoshi S; Kikuchi K; Sasaki T; Sotozono C; Kinoshita S; Hiramatsu K
Antimicrob Agents Chemother; 2008 Aug; 52(8):2970-3. PubMed ID: 18490505
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of anesthetic solutions and preservatives: an in vitro comparative study.
Dantas PE; Uesugui E; Nishiwaki-Dantas MC; Mimica LJ
Cornea; 2000 May; 19(3):353-4. PubMed ID: 10832698
[TBL] [Abstract][Full Text] [Related]
13. Control of microbial contamination in unpreserved eyedrops.
Oldham GB; Andrews V
Br J Ophthalmol; 1996 Jul; 80(7):588-91. PubMed ID: 8795368
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial preservative effectiveness of natural peptide antibiotics.
Kamysz W; Turecka K
Acta Pol Pharm; 2005; 62(5):341-4. PubMed ID: 16459482
[TBL] [Abstract][Full Text] [Related]
15. A case study of preservation of semi-solid preparations using the European Pharmacopoeia test: comparative efficacy of antimicrobial agents in zinc gelatin.
Favet J; Chappuis ML; Doelker E
Eur J Pharm Biopharm; 2001 Sep; 52(2):255-9. PubMed ID: 11522494
[TBL] [Abstract][Full Text] [Related]
16. The importance of the cosolvent propylene glycol on the antimicrobial preservative efficacy of a pharmaceutical formulation by DOE-ruggedness testing.
De Spiegeleer B; Wattyn E; Slegers G; Van der Meeren P; Vlaminck K; Van Vooren L
Pharm Dev Technol; 2006; 11(3):275-84. PubMed ID: 16895838
[TBL] [Abstract][Full Text] [Related]
17. In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.
Haas W; Pillar CM; Hesje CK; Sanfilippo CM; Morris TW
J Antimicrob Chemother; 2011 Apr; 66(4):840-4. PubMed ID: 21393192
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
[TBL] [Abstract][Full Text] [Related]
19. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the preservative effectiveness of RGP lens care solutions.
Keeven J; Wrobel S; Portoles M; DeCicco BT
CLAO J; 1995 Oct; 21(4):238-41. PubMed ID: 8565192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
